Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 07:50 PM EDT
Mereo BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 361.1K | 894.53K | 9.68M | 13.25M | 13.72M | 13.86M | 5.07M | 1.97M | 1.14M | 770.97K | 51.41M | 76.08M | 76.08M | 75.77M | 25.13M |
Cost of Revenue | 257.29K | 532.13K | 749.05K | 921.95K | 4.19M | 5.14M | 4.6M | 4.77M | 1.33M | 331.31K | 1.17M | 991.56K | 26.45M | 38.72M | 38.96M | 38.81M | 14.54M |
Gross Profit | -257.29K | -532.13K | -387.95K | -27.42K | 5.49M | 8.11M | 9.12M | 9.09M | 3.74M | 1.64M | -37.38K | -220.59K | 24.96M | 37.36M | 37.12M | 36.96M | 10.59M |
Operating Income | -48.66M | -47.36M | -37.78M | -34.57M | -37.51M | -32.56M | -52.42M | -58.97M | -71.47M | -80.84M | -83.85M | -85.1M | -57.14M | -42.95M | -41.65M | -41.15M | -48.02M |
Interest Income | 3.08M | 3.04M | 2.16M | 1.18M | 990.2K | 680.7K | 1.29M | 2.04M | 1.89M | 2.57M | 3.23M | 3.75M | 4.84M | 5.15M | 6.24M | 7.2M | 5.89M |
Pretax Income | -47.19M | -43.25M | -42.01M | -33.33M | -35.8M | -32.82M | -46.04M | -49.01M | -60.08M | -67.18M | -43.6M | -32.06M | 8.87M | 29.45M | -27.78M | -56.06M | -134.25M |
Net Income | -47.19M | -43.25M | -42.25M | -33.81M | -35.16M | -31.72M | -43.34M | -46.12M | -57.35M | -64.42M | -45.89M | -36.12M | 5.5M | 26.42M | -25.39M | -50.98M | -130.08M |
Selling & General & Admin | 27.8M | 26.43M | 23.57M | 20.15M | 23.55M | 22.42M | 31.03M | 35.53M | 35.15M | 36.18M | 33.35M | 30.96M | 31.75M | 31.92M | 38.78M | 42.28M | 33.51M |
Research & Development | 20.87M | 20.93M | 15M | 15.01M | 19.81M | 19.76M | 30.55M | 33.9M | 41.43M | 46.23M | 51.23M | 53.92M | 50.34M | 48.39M | 39.99M | 35.83M | 26.38M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -6K | -6K | -6K | -6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.29M |
Operating Expenses | 48.66M | 47.36M | 38.48M | 36.14M | 44.34M | 42.44M | 61.92M | 63.78M | 70.93M | 75.24M | 77.41M | 71.87M | 69.08M | 60.58M | 59.05M | 79.49M | 46.97M |
Interest Expense | 1.24M | 1.37M | 994K | 641K | 1.34M | 1.83M | 3.25M | 3.25M | 4.42M | 3.62M | 2.2M | 2.2M | n/a | n/a | n/a | n/a | -1.41M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 6.5M | 6.5M | 12.32M | 12.32M | 12.29M | 12.29M | 10.94M | 10.94M | 10.15M | 10.15M | 13.02M | 13.02M | 7.33M |
Cost & Expenses | 38M | 47.9M | 38.7M | 36.53M | 48.26M | 47.58M | 66.52M | 68.55M | 72.26M | 75.57M | 78.58M | 72.86M | 95.54M | 99.31M | 98.01M | 118.3M | 60.23M |
Income Tax Expense | n/a | n/a | 244.47K | 480.05K | -638.44K | -184.94K | -1.79M | -1.98M | -1.82M | -1.79M | 3.25M | 5.03M | 4.34M | 4.67M | -758.73K | -1.71M | -810.12K |
Shares Outstanding (Basic) | 156.86M | 155.15M | 154.03M | 142.35M | 140.05M | 138.37M | 138.37M | 125.69M | 124.79M | 112.84M | 114.47M | 116.78M | 116.78M | 116.73M | 107.83M | 98.92M | 83.36M |
Shares Outstanding (Diluted) | 156.86M | 155.15M | 154.03M | 142.35M | 140.05M | 138.36M | 138.36M | 125.68M | 124.79M | 124.5M | 124.5M | 116.78M | 116.78M | 116.73M | 112.66M | 108.58M | 88.19M |
EPS (Basic) | -930.85 | -1.25K | -1.53K | -1.32K | -956.7 | -1.12K | -1.23K | -1.36K | -1.79K | -1.85K | -1.43K | -993.2 | 354.55 | 1.33K | -2.48K | -3.6K | -20.85K |
EPS (Diluted) | -930.85 | -1.25K | -1.53K | -1.32K | -956.7 | -1.12K | -1.27K | -1.43K | -1.86K | -1.93K | -1.47K | -1.71K | -440.1 | 38.00 | -3.77K | -4.17K | -21.35K |
EBITDA | -44.53M | -42.16M | -42.27M | -35.18M | -23.18M | -25.14M | -43.32M | -50.2M | -77.86M | -81.1M | -83.02M | -82.79M | -55.01M | -40.93M | -40.32M | -39.52M | -49.31M |
EBIT | -33.75M | -42.39M | -42.47M | -35.34M | -24.14M | -26.78M | -32.73M | -39.41M | -51.96M | -55.01M | -55.82M | -55.59M | -42.45M | -28.27M | -28.53M | -28.03M | -38.23M |
Depreciation & Amortization | 813K | 1.09M | 1.05M | 1.01M | 1.26M | 1.21M | 1.33M | 1.12M | 1.16M | 1.22M | 1.38M | 1.38M | 1.2M | 1.09M | 1.33M | 1.63M | 2.55M |